GO:0099528 G protein-coupled neurotransmitter receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0099528 describes the molecular function of receptors that bind a neurotransmitter and transmit the signal across the membrane by activating a heterotrimeric G-protein, promoting GDP-to-GTP exchange on the G-alpha subunit [1,2].
• This activity is mediated by classical metabotropic receptors such as GABA-B, metabotropic glutamate receptors, serotonin receptors, dopamine receptors, and the newly deorphanized metabotropic glycine receptor GPR158 [1,2,5,7,8].
• The defining biochemical event is G-protein activation: agonist binding stabilizes an active receptor conformation that acts as a guanine nucleotide exchange factor for G-alpha [2,8].
• Dysregulation of G protein-coupled neurotransmitter receptor activity is implicated in pain, neuropsychiatric disorders, metabolic inflammation, and tumor-induced renal dysfunction [1,3,4].
• Key research methods include CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression, pharmacological profiling, and CRISPR library screening [1,2,5,7].
• EDITGENE provides end-to-end CRISPR cell model and screening services to dissect the causal roles of these receptors in health and disease.
Description
G protein-coupled neurotransmitter receptor activity (GO:0099528) is a molecular function that defines how a large class of membrane receptors converts the binding of a neurotransmitter into an intracellular G-protein signal [1,2]. These receptors are not ion channels; instead, they activate heterotrimeric G-proteins, which then modulate downstream effectors and cellular excitability [2,8]. This function is central to neuromodulation, synaptic plasticity, and the physiological actions of neurotransmitters such as GABA, glutamate, serotonin, dopamine, and glycine [1,2,5,7,8]. Because these receptors are major drug targets, understanding their mechanism, regulation, and disease relevance is a high priority in neuroscience and pharmacology [1,5,6]. The QuickGO definition states that the activity combines with a neurotransmitter and transmits the signal across the membrane by activating an associated G-protein, promoting the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. This article reviews the ontology, mechanism, key genes, disease links, and research methods for GO:0099528, with a focus on how CRISPR-based models can accelerate discovery [1,2,5,7,8].
G protein-coupled neurotransmitter receptor activity At A Glance
| GO ID | GO:0099528 |
|---|---|
| GO term | G protein-coupled neurotransmitter receptor activity |
| Ontology | molecular_function |
| Synonym | G-protein coupled neurotransmitter receptor activity |
| Major function | Binds a neurotransmitter and activates a heterotrimeric G-protein by promoting GDP-to-GTP exchange on the alpha subunit [2,8] |
| Representative receptors | GABA-B, metabotropic glutamate receptors, serotonin receptors, dopamine receptors, GPR158, GPR35 [1,2,3,5,7,8] |
| Signaling consequence | Modulation of downstream effectors such as ion channels and second-messenger enzymes [2,8] |
| Disease relevance | Pain, neuropsychiatric disorders, metabolic inflammation, tumor-induced renal dysfunction [1,3,4] |
| Research methods | CRISPR KO, point mutation, knock-in, overexpression, pharmacological profiling, CRISPR screening [1,2,5,7] |
What Is GO:0099528?
In simple terms, GO:0099528 is the activity of a receptor that binds a neurotransmitter outside the cell and, as a result, switches on a G-protein inside the cell. The receptor acts like a molecular relay: neurotransmitter binding changes the receptor shape, allowing it to interact with a heterotrimeric G-protein and catalyze the exchange of GDP for GTP on the G-alpha subunit [2,8]. This function is distinct from ionotropic receptor activity because it does not directly open an ion channel; instead, it initiates a cascade of intracellular signaling events [1,2]. The term is a molecular function in the Gene Ontology and is synonymous with G-protein coupled neurotransmitter receptor activity [1,2,8].
Why Is G protein-coupled neurotransmitter receptor activity Important in Cell Biology?
GO:0099528 is important because it defines the primary mechanism by which neurotransmitters exert slow, modulatory control over neuronal and non-neuronal cells [1,2,6]. Unlike fast ionotropic transmission, G protein-coupled neurotransmitter receptor activity shapes network excitability, synaptic plasticity, and behavior over seconds to minutes [2,6,8]. Many clinically used drugs, including analgesics, antipsychotics, and antidepressants, target these receptors or their downstream G-protein pathways [1,5]. Moreover, emerging evidence links these receptors to metabolic and inflammatory diseases and to cancer-associated syndromes, making them attractive for therapeutic development [3,4]. Understanding this activity at the molecular level is therefore essential for both basic neuroscience and translational medicine [1,2,5,7,8].
• Defines the molecular function of metabotropic neurotransmitter receptors that activate heterotrimeric G-proteins [2,8].
• Underlies neuromodulation by GABA, glutamate, serotonin, dopamine, and glycine in the nervous system [1,2,5,7,8].
• Represents a major drug target class for pain, anxiety, depression, and psychosis [1,5].
• Links neurotransmitter signaling to metabolic homeostasis and inflammation through receptors such as GPR35.
• Contributes to tumor-induced renal dysfunction via antidiuretic hormone receptors.
• Provides a mechanistic entry point for studying GPCR kinase regulation and receptor desensitization.
• Enables investigation of receptor heteromerization and neuromodulation in brain regions such as the claustrum.
• Supports structural biology efforts to understand lipid and ligand regulation of serotonin receptors.
• Facilitates CRISPR-based functional genomics to identify causal receptor genes in disease models [1,2,5,7].
• Offers opportunities for targeted cell model generation to test receptor-specific therapeutics [1,2,3,4].
What Happens During G protein-coupled neurotransmitter receptor activity?
Neurotransmitter binding and receptor activation
In simple terms: A neurotransmitter docks onto the receptor, causing the receptor to change shape and become active.
The first step in GO:0099528 is the binding of a neurotransmitter to the extracellular or transmembrane pocket of a G protein-coupled receptor [1,2,7]. This binding stabilizes an active receptor conformation, which is necessary for engaging the G-protein [2,8]. For example, GABA binds GABA-B receptors to modulate pain pathways, while glycine activates the orphan receptor GPR158, now recognized as a metabotropic glycine receptor. Structural studies of serotonin receptors have revealed how lipids and ligands regulate this activation step. Metabotropic glutamate receptors similarly undergo conformational changes upon glutamate binding to initiate signaling.
G-protein coupling and GDP-to-GTP exchange
In simple terms: The active receptor acts like a switch that loads a G-protein with GTP, turning it on.
Once active, the receptor interacts with a heterotrimeric G-protein complex composed of alpha, beta, and gamma subunits [2,8]. The receptor functions as a guanine nucleotide exchange factor, promoting the release of GDP and the binding of GTP to the G-alpha subunit [2,8]. This exchange is the defining biochemical event of GO:0099528. The activated G-alpha-GTP then dissociates from the beta-gamma dimer and modulates downstream effectors [2,8]. This mechanism is conserved across metabotropic glutamate receptors and other neurotransmitter receptors.
Downstream effector modulation and signal transmission
In simple terms: The activated G-protein sends a signal inside the cell by turning other proteins on or off.
After GTP loading, the G-alpha subunit and the beta-gamma dimer regulate enzymes such as adenylyl cyclase or ion channels, thereby transmitting the neurotransmitter signal across the membrane [2,8]. This downstream modulation can alter neuronal excitability, neurotransmitter release, and gene expression [2,6,8]. In the claustrum, G protein-coupled receptor neuromodulation influences network activity. The duration and strength of the signal are further controlled by receptor kinases and arrestins.
Receptor desensitization and recycling
In simple terms: After signaling, the receptor is turned off and recycled to prevent overstimulation.
G protein-coupled receptor kinases phosphorylate activated receptors, promoting arrestin binding and desensitization. This regulation is critical for dopamine receptor function and for maintaining normal neurotransmission. The receptor can then be internalized and either recycled back to the membrane or degraded. This step ensures that GO:0099528 activity is tightly controlled in time and space [5,6].
Key Genes Involved in GO:0099528 G protein-coupled neurotransmitter receptor activity
The following genes encode receptors or signaling components that carry out or regulate G protein-coupled neurotransmitter receptor activity (GO:0099528).
| Gene | Major Role | Research Relevance |
|---|---|---|
| GABBR1 | GABA-B receptor subunit that binds GABA and activates G-proteins | Pain and analgesia research; knockout models for GABAergic signaling |
| GABBR2 | GABA-B receptor subunit required for heterodimeric receptor function | Studies of receptor assembly and pain pathways |
| GPR158 | Metabotropic glycine receptor that activates G-proteins | Orphan receptor deorphanization and neuromodulation |
| GPR35 | Receptor for kynurenic acid linked to energy homeostasis | Metabolic and inflammatory disease models |
| ADH receptor (e.g., AVPR2) | Antidiuretic hormone receptor involved in renal function | Tumor-induced renal dysfunction research |
| DRD1 | Dopamine receptor coupled to Gs signaling | Dopamine signaling and neuropsychiatric studies |
| DRD2 | Dopamine receptor coupled to Gi signaling | Antipsychotic drug target research |
| HTR1A | Serotonin receptor coupled to Gi signaling | Depression and anxiety research |
| HTR2A | Serotonin receptor coupled to Gq signaling | Structural and pharmacological studies |
| GRM1 | Metabotropic glutamate receptor 1 | Glutamate signaling and synaptic plasticity |
| GRM5 | Metabotropic glutamate receptor 5 | Drug discovery for neurological disorders |
| GRK2 | G protein-coupled receptor kinase that desensitizes receptors | Regulation of dopamine receptor function |
| GRK3 | G protein-coupled receptor kinase involved in receptor phosphorylation | Studies of desensitization mechanisms |
| ARRB1 | Beta-arrestin 1 that mediates receptor internalization | Receptor trafficking research |
| ARRB2 | Beta-arrestin 2 that mediates receptor internalization | Signal termination studies |
| GNAI1 | G-alpha i subunit that inhibits adenylyl cyclase | G-protein coupling specificity research |
| GNAS | G-alpha s subunit that stimulates adenylyl cyclase | cAMP signaling studies |
| GNAQ | G-alpha q subunit that activates phospholipase C | Calcium signaling research |
How Is G protein-coupled neurotransmitter receptor activity Regulated?
The activity of G protein-coupled neurotransmitter receptors is regulated at multiple levels. G protein-coupled receptor kinases (GRKs) phosphorylate activated receptors, leading to arrestin recruitment and desensitization. This mechanism is well characterized for dopamine receptors, where GRK2 and GRK3 modulate receptor responsiveness. Receptor heteromerization can also alter signaling properties, as seen in the claustrum where GPCR neuromodulation depends on receptor composition. Additionally, lipid environment and ligand availability regulate receptor activation, as demonstrated for serotonin receptors. These regulatory layers ensure that GO:0099528 activity is dynamically tuned to physiological needs [5,6,7].
G protein-coupled neurotransmitter receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GABBR1 | Pain and analgesia | Knockout mice or cells for pain behavior studies |
| GPR35 | Metabolic inflammation and obesity | Adipose-specific knockout or overexpression models |
| AVPR2 | Tumor-induced renal dysfunction | Xenograft models with receptor knockdown |
| DRD2 | Neuropsychiatric disorders | Point-mutation knock-in for signaling bias |
| HTR2A | Depression and anxiety | Knock-in models for structural studies |
Pain and analgesia
GABA-B receptors, which mediate G protein-coupled neurotransmitter receptor activity, are key targets for pain modulation. Subtype-selective agonists and positive allosteric modulators have shown analgesic efficacy in preclinical models. Dysregulation of GABAergic signaling contributes to chronic pain states, making these receptors attractive for therapeutic development.
Neuropsychiatric and neurological disorders
Dopamine and serotonin receptors are central to mood, reward, and psychosis [5,7]. G protein-coupled receptor kinases regulate dopamine receptor function, and their dysfunction has been implicated in neuropsychiatric conditions. Structural insights into serotonin receptors have advanced drug design for depression and anxiety. Metabotropic glutamate receptors are also implicated in synaptic dysfunction and neurodegeneration.
Metabolic and inflammatory diseases
GPR35, activated by kynurenic acid, regulates adipose tissue energy homeostasis and inflammation. This links G protein-coupled neurotransmitter receptor activity to metabolic disorders and immune regulation. Targeting GPR35 may offer new strategies for obesity and inflammatory diseases.
Tumor-induced renal dysfunction
A novel antidiuretic hormone and its receptor govern tumor-induced renal dysfunction. This demonstrates that G protein-coupled neurotransmitter receptor activity can be hijacked in cancer to cause paraneoplastic syndromes. Understanding this axis may lead to new treatments for cancer-associated kidney injury.
From G protein-coupled neurotransmitter receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of receptor function alter neurotransmission? | CRISPR knockout cell lines or animals [1,2] |
| How does a specific point mutation affect G-protein coupling? | Point-mutation knock-in via CRISPR [5,7] |
| Where is the receptor expressed and trafficked? | Tagged knock-in with fluorescent or epitope tag [2,5] |
| Does overexpression mimic disease phenotypes? | Stable overexpression cell lines [3,4] |
| Which genes modulate receptor signaling? | CRISPR library screening [1,2,5,7] |
| Can pharmacological rescue restore function? | Knockout plus drug treatment models [1,3] |
How to Study the G protein-coupled neurotransmitter receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of receptor function | Testing causality in disease models [1,2] |
| Point-mutation knock-in | Effect of specific amino acid changes | Structure-function studies [5,7] |
| Tagged knock-in | Receptor localization and trafficking | Live-cell imaging [2,5] |
| Overexpression | Gain-of-function phenotypes | Disease modeling [3,4] |
| cAMP assay | G-alpha s or i activity | Pharmacological profiling [1,2] |
| Calcium flux assay | G-alpha q activity | Receptor activation studies [7,8] |
| CRISPR library screening | Genes affecting receptor signaling | Unbiased target discovery [1,2,5,7] |
| Bioinformatics | Pathway and network analysis | Interpreting screen hits [1,2] |
CRISPR knockout and point-mutation models
CRISPR-Cas9 knockout of receptor genes such as GABBR1 or GPR158 can reveal their contribution to G protein-coupled neurotransmitter receptor activity [1,2]. Point-mutation knock-in allows precise testing of residues involved in ligand binding or G-protein coupling [5,7]. These models are essential for establishing causality in disease pathways [1,2,5].
Tagged knock-in and imaging
Tagged knock-in of receptors with fluorescent proteins enables live-cell imaging of receptor trafficking and localization [2,5]. This approach can visualize receptor internalization after agonist stimulation. It is particularly useful for studying dynamic regulation of GO:0099528 [2,5].
Pharmacological profiling and second-messenger assays
Measuring cAMP, calcium, or GTP-loading provides functional readouts of G protein-coupled neurotransmitter receptor activity [1,2,8]. These assays can be combined with CRISPR knockouts to identify receptor-specific effects [1,2]. They are standard in drug discovery for metabotropic receptors [1,8].
CRISPR library screening and bioinformatics
Genome-wide CRISPR screens can identify genes that regulate receptor signaling or desensitization [1,2,5,7]. Bioinformatics analysis of screen hits can reveal pathways linked to GO:0099528 [1,2]. This unbiased approach accelerates target discovery [1,2,5,7].
How CRISPR Can Be Used to Study GO:0099528 G protein-coupled neurotransmitter receptor activity
Knockout
CRISPR knockout of genes encoding G protein-coupled neurotransmitter receptors, such as GABBR1 or GPR158, abolishes receptor activity and allows researchers to test its role in pain, neuromodulation, or behavior [1,2]. Knockout cell lines are also useful for pharmacological specificity controls.
Point Mutation
Point-mutation knock-in can introduce disease-associated or functionally informative mutations into receptor genes [5,7]. For example, mutating residues in the ligand-binding pocket of serotonin receptors can reveal their role in activation. This approach is ideal for dissecting the molecular determinants of GO:0099528 [5,7].
Knock-in
Tagged knock-in of receptors with fluorescent or epitope tags enables visualization of receptor expression and trafficking in native contexts [2,5]. This is valuable for understanding how receptor localization contributes to G protein-coupled neurotransmitter receptor activity [2,5].
Overexpression
Overexpression of receptors such as GPR35 or antidiuretic hormone receptors can mimic disease states and reveal downstream signaling consequences [3,4]. Overexpression models are also used to study receptor desensitization and drug responses [3,4].
How EDITGENE Supports G protein-coupled neurotransmitter receptor activity Research
Researchers studying G protein-coupled neurotransmitter receptor activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of receptors and their regulators [1,2,5,7].
Contact EDITGENE today to design your custom CRISPR model for G protein-coupled neurotransmitter receptor activity research.
Frequently Asked Questions About G protein-coupled neurotransmitter receptor activity
What is G protein-coupled neurotransmitter receptor activity?
It is a molecular function (GO:0099528) where a receptor binds a neurotransmitter and activates a heterotrimeric G-protein by promoting GDP-to-GTP exchange on the alpha subunit [2,8].
What genes are involved in G protein-coupled neurotransmitter receptor activity?
Key genes include GABBR1, GABBR2, GPR158, GPR35, DRD1, DRD2, HTR1A, HTR2A, GRM1, and GRM5, among others [1,2,3,5,7,8].
How does G protein-coupled neurotransmitter receptor activity work?
Neurotransmitter binding activates the receptor, which then acts as a guanine nucleotide exchange factor for G-alpha, leading to downstream signaling [2,8].
What diseases are linked to G protein-coupled neurotransmitter receptor activity?
It is linked to pain, neuropsychiatric disorders, metabolic inflammation, and tumor-induced renal dysfunction [1,3,4,5,7].
What is the GO ID for G protein-coupled neurotransmitter receptor activity?
The GO ID is GO:0099528.
What are the synonyms for GO:0099528?
The synonym is G-protein coupled neurotransmitter receptor activity.
How can CRISPR be used to study G protein-coupled neurotransmitter receptor activity?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression can reveal receptor function and regulation [1,2,5,7].
What model systems are used to study G protein-coupled neurotransmitter receptor activity?
Common models include knockout cell lines, point-mutation knock-in cells, tagged receptor knock-in cells, and overexpression lines [1,2,3,4,5,7].
What is the role of GPR158 in G protein-coupled neurotransmitter receptor activity?
GPR158 is a metabotropic glycine receptor that activates G-proteins, representing a newly deorphanized member of this activity class.
How is G protein-coupled neurotransmitter receptor activity regulated?
It is regulated by G protein-coupled receptor kinases, arrestins, receptor heteromerization, and lipid environment [5,6,7].
Conclusion
G protein-coupled neurotransmitter receptor activity (GO:0099528) is a fundamental molecular function that mediates slow neuromodulation and diverse physiological processes [1,2,6,8]. Its dysregulation contributes to pain, neuropsychiatric disorders, metabolic inflammation, and cancer-associated syndromes [1,3,4,5,7]. Advances in CRISPR technology now allow precise interrogation of the genes and mechanisms underlying this activity [1,2,5,7]. EDITGENE's comprehensive cell model and screening services empower researchers to dissect these pathways and accelerate therapeutic discovery [1,2,3,4,5,7].
References
- 1. Qian X et al.. 2023. Current status of GABA receptor subtypes in analgesia.. Biomed Pharmacother 168:115800 PMID: 37935070
- 2. Laboute T et al.. 2023. Orphan receptor GPR158 serves as a metabotropic glycine receptor: mGlyR.. Science 379(6639):1352-1358 PMID: 36996198
- 3. Agudelo LZ et al.. 2018. Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation.. Cell Metab 27(2):378-392.e5 PMID: 29414686
- 4. Xu W et al.. 2023. A novel antidiuretic hormone governs tumour-induced renal dysfunction.. Nature 624(7991):425-432 PMID: 38057665
- 5. Gurevich EV et al.. 2016. G protein-coupled receptor kinases as regulators of dopamine receptor functions.. Pharmacol Res 111:1-16 PMID: 27178731
- 6. Borroto-Escuela DO et al.. 2020. On the G Protein-Coupled Receptor Neuromodulation of the Claustrum.. Neurochem Res 45(1):5-15 PMID: 31172348
- 7. Xu P et al.. 2021. Structural insights into the lipid and ligand regulation of serotonin receptors.. Nature 592(7854):469-473 PMID: 33762731
- 8. Ferraguti F et al.. 2006. Metabotropic glutamate receptors.. Cell Tissue Res 326(2):483-504 PMID: 16847639
